v3.26.1
Statement of Changes in Shareholders’ Deficit - 12 months ended Dec. 31, 2025 - USD ($)
Ordinary Shares
Class A
Ordinary Shares
Class B
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jan. 06, 2025
Balance (in Shares) at Jan. 06, 2025      
Class B ordinary shares issued to Sponsor [1] $ 767 24,233 25,000
Class B ordinary shares issued to Sponsor (in Shares) [1] 7,665,900      
Accretion of Class A ordinary shares to redemption value (9,934,213) (13,197,752) (23,131,965)
Sale of 660,000 Private Placement Units $ 66 6,599,934 6,600,000
Sale of 660,000 Private Placement Units (in Shares) 660,000        
Fair value of rights included in Public Units 3,404,000 3,404,000
Allocated value of transaction costs to Private Placement Units and rights included in Public Units (226,254) (226,254)
Share-based compensation to director nominees 132,300 132,300
Net income 5,054,949 5,054,949
Balance at Dec. 31, 2025 $ 66 $ 767 $ (8,142,803) $ (8,141,970)
Balance (in Shares) at Dec. 31, 2025 660,000 7,665,900      
[1] Includes an aggregate of up to 999,900 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On May 27, 2025, the Company consummated its Initial Public Offering and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment and as such 999,900 Class B ordinary shares are no longer subject to forfeiture.